ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Potential to Regenerate Damaged Allografts

L. Brasile1, B. Stubentisky2

1Research and Development, Breonics Inc., Watervliet, NY, 2Plastic, Reconstructive & Aesthetic Surgery, St. Antonius Hospital, Utrecht, Netherlands

Meeting: 2020 American Transplant Congress

Abstract number: D-318

Keywords: Cadaveric organs, Kidney, Stem cells, Warm ischemia

Session Information

Session Name: Poster Session D: Cellular Therapies, Tissue Engineering / Regenerative Medicine

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: The chronic shortage of allografts has generated intense interest in the field of regenerative medicine. Given the limited regeneration that can be accomplished in quiescent tissues, normal recovery results in scarring and inadequate restoration of functional capacity. In vivo, the response to injury involves coagulative, inflammatory and adhesion phases that result in the scarring and loss of function. To regenerate damaged organs new cells must replace the lethally damaged cells to restore function. Optimized cell culture supports the completion of the cell cycle in ≥24 hours. The main component of regeneration is cell proliferation that involves DNA replication and mitosis initiated via receptor-mediated signal transduction. We evaluated the potential to use prolonged ex vivo acellular warm perfusion of as much as 72 hours to support regenerative pathways. We evaluated whether replacement of lethally injured cells could be accomplished during an acellular ex vivo warm perfusion environment.

*Methods: An acellular perfusion technology was employed that represents the tissue culture of a whole organ. Regenerative pathways were supported by nutrient, trophic and cytokine supplementation to the recirculating perfusate. Discarded ischemically damaged (>45 minutes WI) human kidney allografts (n=4) were used. Confirmation of renal regeneration was determined by restoration of cytoskeletal integrity (ZO-1), DNA synthesis (S phase) and mitosis (M phase). Image J software was used to objectively quantify fluorescence for ZO-1. The mean number of PCNA-positive nuclei was also quantified objectively using Image J software. The percent of positive toluidine stained cells were also determined per 40 separate fields.

*Results: Stable perfusion dynamics, oxygen consumption, metabolism and synthesis was maintained during the 2-days of ex vivo perfusion. The data listed in Table 1 demonstrates that time dependent normalization of cytoskeleton occurred. Similarly, DNA synthesis increased incrementally and was of sufficient magnitude to result in mitosis during the ex vivo perfusion.

*Conclusions: An acellular environment eliminates the normal in vivo response to injury that results in scarring and enhances regeneration. The observed DNA synthesis and mitosis demonstrates that acellular warm perfusion also holds the potential to support the generation of new cells to replace lethally damaged ones to restore normal function without scarring.

Regenerative Potential of MSC Treatment during Ex Vivo Warm Perfusion
Time (Hours) 0 6 18 24 48
ZO-1 80.0 ± 8.0 76.0 ± 4.0 34.0 ± 7.0 10.0 ± 3.0 6.0 ± 2.0
PCNA 1.0 ± 0.3 4.6 ± 0.8 34.6 ± 2.3 46.4 ± 10.0 54.6 ± 5.4
Mitosis 0 0 10.8 ± 1.2 27.7 ± 1.4 35.4 ± 1.8
*Values represented as the average percent (%) of positive cells per representative field.
  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Brasile L, Stubentisky B. Potential to Regenerate Damaged Allografts [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/potential-to-regenerate-damaged-allografts/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences